Right to Test Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 2, 2021)
Right to Test Act
This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency.
Unless requested by the governor of the state, the Food and Drug Administration (FDA) must not, during the emergency, engage in certain enforcement actions related to such a test or device.
Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.
What just happenedFeb 3, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseFeb 2, 2021
- Feb 3, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 2, 2021IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 2, 2021IntroReferralIntro-H
Introduced in House
- Feb 2, 2021IntroReferral1000
Introduced in House